HOME >> MEDICINE >> NEWS
Study finds Velcade major improvement over standard therapy for relapsed multiple myeloma patients

NEW ORLEANSEarly results from a major, international Phase III clinical trial decisively show that recurrent multiple myeloma is more effectively treated with the drug bortezomib (trade name: Velcade TM) than with dexamethasone, a drug that for decades has been the standard therapy for relapsed disease, researchers at Dana-Farber Cancer Institute report.

The findings, which will be presented at the annual meeting of the American Society of Clinical Oncology (Sunday, June 6, 2 p.m. Room 283) were sufficiently striking that the trial was stopped early so that patients who had been randomly assigned to receive dexamethasone could switch to bortezomib.

The study, which involved 669 patients in 92 treatment centers around the world, was the first head-to-head comparison of bortezomib and dexamethasone in a Phase III trial of patients who had relapsed after treatment for multiple myeloma. (Phase III trials test new treatments against standard ones to determine which is safer and more effective.)

"This trial represents the largest, most broad-based assessment to date of bortezomib and dexamethasone in this group of patients," says the study's lead author, Paul Richardson, MD, of Dana-Farber. "The finding that bortezomib significantly lengthened the time to disease progression and improved survival when compared with dexamethasone, with a similar level of safety, is important confirmatory evidence of bortezomib's effectiveness for patients with relapsed multiple myeloma."

Multiple myeloma is a currently incurable cancer of the bone marrow that causes a plunge in the production of vital red and white blood cells. Although relatively rare, it is the second most common type of blood cancer and accounts for 11,000 deaths annually in the United States. It is the fourth fastest-growing cancer in terms of mortality and is among the top 10 causes of death among African Americans.

In the new stud
'"/>

Contact: Bill Schaller
janet_haley@dfci.harvard.edu
617-233-5507
Dana-Farber Cancer Institute
5-Jun-2004


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 17, 2018 , ... An August 7 article ... premature births and low birth weight could be significantly reduced if women were more ... gingivitis (gum disease) which a very large number of pregnant women suffer from to ...
(Date:8/15/2018)... ... August 15, 2018 , ... Today David Hyde Apparel debuts the first, fully ... out of a desire for confidence and comfort year-round, the new shirt leverages a ... in the hottest, most humid of climates. , The brainchild of two recent University ...
(Date:8/14/2018)... MIAMI (PRWEB) , ... August 14, 2018 , ... ... fastest-growing gastroenterology groups, today announced new leadership roles for healthcare executives Simon Frisch ... Division Vice President, Florida, respectively. They assume their roles at a time of ...
(Date:8/11/2018)... ... 10, 2018 , ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at ... international outpost trip to deliver dental care in impoverished communities. Along with a team ... volunteered his time to help deliver care to over 550 individuals in need. , ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of US ... according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), The ... monitored by the FDA. As an MRI is recommended by FDA after the ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... ... of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. Mr. ... of strategic development, marketing and sales experience in medical device toward finding new and ...
(Date:8/3/2018)... ... August 03, 2018 , ... In order to improve safety for everyone ... be mindful of the significant risks of injury that many amusement park rides present ... the Ferris wheel or a thrilling ride on a roller coaster. Unfortunately, these fun ...
(Date:8/2/2018)... ... August 02, 2018 , ... Periodontist, Dr. Andres ... crown lengthening treatment at his Eden Prairie, MN practice. Aesthetic crown ... self-conscious. Using decades of experience, Dr. Sanchez is excited to welcome new patients ...
Breaking Medicine Technology:
Cached News: